Mediclinic International (LON:MDC) Stock Price Down 0.3%
Mediclinic International PLC (LON:MDC)’s share price fell 0.3% during trading on Thursday . The stock traded as low as GBX 376 ($4.91) and last traded at GBX 377 ($4.93), 484,965 shares changed hands during trading. A decline of 70% from the average session volume of 1,610,000 shares. The stock had previously closed at GBX 378.20 ($4.94).
Separately, UBS Group reissued a “buy” rating and issued a GBX 385 ($5.03) price objective (down from GBX 395 ($5.16)) on shares of Mediclinic International in a report on Monday, October 14th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Mediclinic International currently has a consensus rating of “Hold” and an average price target of GBX 374.75 ($4.90).
The company has a quick ratio of 1.71, a current ratio of 1.86 and a debt-to-equity ratio of 60.75. The company has a market cap of $2.78 billion and a PE ratio of -18.39. The stock has a 50-day simple moving average of GBX 356.64 and a 200 day simple moving average of GBX 334.15.
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 private acute care hospitals and 4 clinics with approximately 1,805 inpatient beds in Switzerland; 49 acute care private hospitals and 2 day clinics in South Africa, and 3 hospitals in Namibia with approximately 8,131 inpatient beds; and 6 acute care private hospitals and 22 clinics with approximately 748 inpatient beds in the United Arab Emirates.
Featured Story: Trading Strategy
Receive News & Ratings for Mediclinic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International and related companies with MarketBeat.com's FREE daily email newsletter.